{
  "links": "https://www.ycombinator.com/companies/verge-genomics",
  "name": "Verge Genomics",
  "headline": "We use human data and AI to develop better drugs faster.",
  "batch": "S15",
  "description": "Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.",
  "activity_status": "Active",
  "website": "http://vergegenomics.com",
  "founded_date": 2015.0,
  "team_size": 50.0,
  "location": "San Francisco",
  "group_partner": "Dalton Caldwell",
  "group_partner_yc": "https://www.ycombinator.com/people/dalton-caldwell",
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:ai-powered-drug-discovery; industry:biotech; industry:healthcare; location:san-francisco-bay-area",
  "founders": [],
  "status": true,
  "markdown": "raw_markdown=\"Press Alt+1 for screen-reader mode, Alt+0 to cancel[Accessibility Screen-Reader Guide, Feedback, and Issue Reporting](http://vergegenomics.com/<https:/accessibe.com/blog/knowledgebase/screen-reader-guide>)\\n[ ![Verge Genomics](http://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/8f1fc7c2-94a2-4f4c-abc2-480e6fecc38c/vg-pl-b.png) ](http://vergegenomics.com/</>)\\n[ ](http://vergegenomics.com/</search>)\\n[ Leadership ](http://vergegenomics.com/</about>) [ Approach ](http://vergegenomics.com/</approach>) [ Pipeline ](http://vergegenomics.com/</pipeline>) [ Partnerships ](http://vergegenomics.com/</partnerships>) [ News ](http://vergegenomics.com/</news>) [ Careers ](http://vergegenomics.com/</join-us>)\\n[ ](http://vergegenomics.com/<https:/twitter.com/VergeGenomics>)[ ](http://vergegenomics.com/<https:/www.linkedin.com/company/verge-genomics/>)\\n[Leadership](http://vergegenomics.com/</about>)[Approach](http://vergegenomics.com/</approach>)[Pipeline](http://vergegenomics.com/</pipeline>)[Partnerships](http://vergegenomics.com/</partnerships>)[News](http://vergegenomics.com/</news>)[Careers](http://vergegenomics.com/</join-us>)\\n[ ![Verge Genomics](http://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/8f1fc7c2-94a2-4f4c-abc2-480e6fecc38c/vg-pl-b.png) ](http://vergegenomics.com/</>)\\nScroll\\n# We are building the next enduring biotechnology company of the digital age.\\nVerge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical challenges of our time.\\n[ See our approach ](http://vergegenomics.com/</approach>)\\n## **Our mission is to develop better drugs, faster using technology.**\\nVerge was born from the convergence of multiple technological forces, including human genomics, machine learning, biological engineering, and translational medicine, that are enabling us to decipher biology. Instead of using animal or cell models, we have built one of the world's largest proprietary multi-omics databases directly from human tissue. We use machine learning to map the complex causes of disease and develop those insights into proprietary drug candidates on our internal biology and chemistry platforms.\\n### **In order to succeed in humans, we start in humans.**\\n[EXPLORE OUR APPROACH →](http://vergegenomics.com/</approach>)\\n## We are developing drugs to treat the biggest medical challenges of our generation.\\nOur first drug VRG50635, a small molecule inhibitor of PIKfyve, has entered the clinic for amyotrophic lateral sclerosis (ALS). It was discovered by CONVERGE®, Verge’s all-in-human, AI-powered platform, moving from research to clinic in just four years. We are working on a dozen breakthrough opportunities on Parkinson's Disease, Frontotemporal Dementia, and other devastating diseases with no effective treatments to date.\\n[See our pipeline →](http://vergegenomics.com/</pipeline>)\\n## **We are collaborating with industry leaders to transform drug discovery.**\\n[Partner with us →](http://vergegenomics.com/</partnerships>)\\n## We are a team of drug hunters, engineers, and neuroscientists united around an audacious vision.\\n[Meet our Team →](http://vergegenomics.com/</about>)\\n## **We are pioneering a new type of culture in biotech.**\\n[Work WIth US →](http://vergegenomics.com/</join-us>)\\n[ Welcome ](http://vergegenomics.com/<#welcome>) [ About ](http://vergegenomics.com/<#hp-about>) [ pipeline ](http://vergegenomics.com/<#hp-pipeline>) [ Partnerships ](http://vergegenomics.com/<#hp-partnerships>) [ Meet the team ](http://vergegenomics.com/<#meet-the-team>) [ Work with us ](http://vergegenomics.com/<#work-with-us>)\\n  * [Home](http://vergegenomics.com/</home>)\\n  * [Leadership](http://vergegenomics.com/</about>)\\n  * [Approach](http://vergegenomics.com/</approach>)\\n  * [Pipeline](http://vergegenomics.com/</pipeline>)\\n  * [ Accessibility ](http://vergegenomics.com/<#>)\\n\\n\\n  * [Partnerships](http://vergegenomics.com/</partnerships>)\\n  * [News](http://vergegenomics.com/</news>)\\n  * [Careers](http://vergegenomics.com/</join-us>)\\n  * [Privacy](http://vergegenomics.com/</privacy>)\\n\\n\\n![Verge Genomics Logo](https://vergegenomics.com/s/vergelogo_Verge-White.svg)\\n131 Oyster Point BlvdSuite 300 South San FranciscoCA 94080\\n  * [![LinkedIn icon graphic](http://vergegenomics.com/s/li.svg)](http://vergegenomics.com/<https:/linkedin.com/company/verge-genomics>)\\n[![X logo icon graphic](http://vergegenomics.com/s/x.svg)](http://vergegenomics.com/<https:/twitter.com/VergeGenomics>)\\n\\n\\n  * [**info@vergegenomics.com**](http://vergegenomics.com/<mailTo:info@vergegenomics.com>)\\n\\n\\nCopyright 2023\\n\" markdown_with_citations=\"Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting⟨1⟩\\n ![Verge Genomics⟨2⟩ ](http://vergegenomics.com/</>)\\n ⟨3⟩\\n Leadership ⟨4⟩  Approach ⟨5⟩  Pipeline ⟨6⟩  Partnerships ⟨7⟩  News ⟨8⟩  Careers ⟨9⟩\\n ⟨10⟩ ⟨11⟩\\nLeadership⟨4⟩Approach⟨5⟩Pipeline⟨6⟩Partnerships⟨7⟩News⟨8⟩Careers⟨9⟩\\n ![Verge Genomics⟨2⟩ ](http://vergegenomics.com/</>)\\nScroll\\n# We are building the next enduring biotechnology company of the digital age.\\nVerge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical challenges of our time.\\n See our approach ⟨5⟩\\n## **Our mission is to develop better drugs, faster using technology.**\\nVerge was born from the convergence of multiple technological forces, including human genomics, machine learning, biological engineering, and translational medicine, that are enabling us to decipher biology. Instead of using animal or cell models, we have built one of the world's largest proprietary multi-omics databases directly from human tissue. We use machine learning to map the complex causes of disease and develop those insights into proprietary drug candidates on our internal biology and chemistry platforms.\\n### **In order to succeed in humans, we start in humans.**\\nEXPLORE OUR APPROACH →⟨5⟩\\n## We are developing drugs to treat the biggest medical challenges of our generation.\\nOur first drug VRG50635, a small molecule inhibitor of PIKfyve, has entered the clinic for amyotrophic lateral sclerosis (ALS). It was discovered by CONVERGE®, Verge’s all-in-human, AI-powered platform, moving from research to clinic in just four years. We are working on a dozen breakthrough opportunities on Parkinson's Disease, Frontotemporal Dementia, and other devastating diseases with no effective treatments to date.\\nSee our pipeline →⟨6⟩\\n## **We are collaborating with industry leaders to transform drug discovery.**\\nPartner with us →⟨7⟩\\n## We are a team of drug hunters, engineers, and neuroscientists united around an audacious vision.\\nMeet our Team →⟨4⟩\\n## **We are pioneering a new type of culture in biotech.**\\nWork WIth US →⟨9⟩\\n Welcome ⟨12⟩  About ⟨13⟩  pipeline ⟨14⟩  Partnerships ⟨15⟩  Meet the team ⟨16⟩  Work with us ⟨17⟩\\n  * Home⟨18⟩\\n  * Leadership⟨4⟩\\n  * Approach⟨5⟩\\n  * Pipeline⟨6⟩\\n  *  Accessibility ⟨19⟩\\n\\n\\n  * Partnerships⟨7⟩\\n  * News⟨8⟩\\n  * Careers⟨9⟩\\n  * Privacy⟨20⟩\\n\\n\\n![Verge Genomics Logo⟨21⟩]\\n131 Oyster Point BlvdSuite 300 South San FranciscoCA 94080\\n  * ![LinkedIn icon graphic⟨22⟩](http://vergegenomics.com/<https:/linkedin.com/company/verge-genomics>)\\n![X logo icon graphic⟨23⟩](http://vergegenomics.com/<https:/twitter.com/VergeGenomics>)\\n\\n\\n  * **info@vergegenomics.com**⟨24⟩\\n\\n\\nCopyright 2023\\n\" references_markdown='\\n\\n## References\\n\\n⟨1⟩ http://vergegenomics.com/<https:/accessibe.com/blog/knowledgebase/screen-reader-guide>: Accessibility Screen-Reader Guide, Feedback, and Issue Reporting\\n⟨2⟩ http://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/8f1fc7c2-94a2-4f4c-abc2-480e6fecc38c/vg-pl-b.png:  ![Verge Genomics\\n⟨3⟩ http://vergegenomics.com/</search>:  \\n⟨4⟩ http://vergegenomics.com/</about>:  Leadership \\n⟨5⟩ http://vergegenomics.com/</approach>:  Approach \\n⟨6⟩ http://vergegenomics.com/</pipeline>:  Pipeline \\n⟨7⟩ http://vergegenomics.com/</partnerships>:  Partnerships \\n⟨8⟩ http://vergegenomics.com/</news>:  News \\n⟨9⟩ http://vergegenomics.com/</join-us>:  Careers \\n⟨10⟩ http://vergegenomics.com/<https:/twitter.com/VergeGenomics>:  \\n⟨11⟩ http://vergegenomics.com/<https:/www.linkedin.com/company/verge-genomics/>:  \\n⟨12⟩ http://vergegenomics.com/<#welcome>:  Welcome \\n⟨13⟩ http://vergegenomics.com/<#hp-about>:  About \\n⟨14⟩ http://vergegenomics.com/<#hp-pipeline>:  pipeline \\n⟨15⟩ http://vergegenomics.com/<#hp-partnerships>:  Partnerships \\n⟨16⟩ http://vergegenomics.com/<#meet-the-team>:  Meet the team \\n⟨17⟩ http://vergegenomics.com/<#work-with-us>:  Work with us \\n⟨18⟩ http://vergegenomics.com/</home>: Home\\n⟨19⟩ http://vergegenomics.com/<#>:  Accessibility \\n⟨20⟩ http://vergegenomics.com/</privacy>: Privacy\\n⟨21⟩ https://vergegenomics.com/s/vergelogo_Verge-White.svg: Verge Genomics Logo\\n⟨22⟩ http://vergegenomics.com/s/li.svg: ![LinkedIn icon graphic\\n⟨23⟩ http://vergegenomics.com/s/x.svg: ![X logo icon graphic\\n⟨24⟩ http://vergegenomics.com/<mailTo:info@vergegenomics.com>: **info@vergegenomics.com**\\n' fit_markdown='' fit_html=''",
  "generated_description": "**Verge Genomics: Revolutionizing Drug Discovery with AI and Human Data**\n\nFounded in 2015 as part of Y Combinator's S15 batch, Verge Genomics is carving a niche in the biotechnology sector by leveraging artificial intelligence (AI) and extensive human data to expedite drug development. Based in San Francisco with a dynamic team of around 50, the company champions the mission of delivering better drugs faster by harnessing cutting-edge technology.\n\nVerge has developed an innovative, all-in-human drug discovery platform known as CONVERGE®, utilizing a massive proprietary multi-omics database sourced directly from human tissue. This contrasts sharply with traditional methods that often rely on animal or cell models. By applying advanced machine learning techniques, Verge uncovers insights into the complex causes of diseases, aiming to transform these insights into promising drug candidates.\n\nThe company is focused on tackling significant medical challenges, such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, and frontotemporal dementia—conditions currently without effective treatments. Notably, Verge's first drug, VRG50635, a small molecule inhibitor aimed at ALS, has already progressed to clinical trials in just four years. This rapid transition from research to clinic encapsulates their commitment to accelerating drug discovery.\n\nUnder the leadership of Dalton Caldwell, Verge is not just a biotech firm; it's a culture of innovation, collaboration, and relentless pursuit of breakthroughs in healthcare. They are actively seeking partnerships with industry leaders to reshape the drug discovery landscape.\n\nIf you're curious to learn more about how Verge Genomics is revolutionizing biotech and what they are working on, visit their [website](http://vergegenomics.com).\n\nIn essence, Verge Genomics stands at the confluence of human biology and machine intelligence, driving forward the next wave of therapeutic innovations. They are an example of how technology can fundamentally change the landscape of medicine and drug development."
}